ICD-10 diagnosis code

P96.2 Withdrawal symptoms from therapeutic use of drugs in newborn

This page in Swedish

P96.2 is the ICD-10 code for Withdrawal symptoms from therapeutic use of drugs in newborn. It is a four-character subcategory of P96 (Other conditions originating in the perinatal period), the most specific level in the WHO edition. It belongs to the block P90–P96 (Other disorders originating in the perinatal period) in Chapter XVI, Certain conditions originating in the perinatal period.

Code type
Subcategory (4 characters)
Chapter
XVI · P00–P96
Classification
WHO ICD-10, 2019 version

P96.2 in national editions

Countries report with their own edition of ICD-10. Most keep the WHO code and add more specific codes beneath it.

NorwayICD-10-NO

P96.2Abstinenssymptom hos nyfødt etter behandling med legemidler

DenmarkICD-10-DK

DP962Abstinenser hos nyfødt ved terapeutisk brug af lægemiddel

FinlandICD-10-FI

P96.2Hoidoksi annettujen lääkeaineiden aiheuttamat vastasyntyneen vieroitusoireet

GermanyICD-10-GM

P96.2Entzugssymptome bei therapeutischer Anwendung von Arzneimitteln beim Neugeborenen

FranceICD-10-FR

P96.2Symptômes de sevrage après utilisation thérapeutique de médicaments chez le

NetherlandsICD-10-NL

P96.2ontwenningsverschijnselen door therapeutisch gebruik van geneesmiddelen

United StatesICD-10-CM

P96.2Withdrawal symptoms from therapeutic use of drugs in newborn

Based on the World Health Organization’s International Statistical Classification of Diseases and Related Health Problems, 10th revision (ICD-10), 2019 version, and the national editions published by each country’s health authority. This page is a reference, not coding advice; follow your national coding rules when you report.

Look up another code

Stop looking codes up by hand

Docdemic listens to the consultation, writes the note and suggests the diagnosis and procedure codes that fit it, each one checked against your country’s official code list.

Try Docdemic free